Still looks rather controversi

2021-06-08

Still looks rather controversial. With an independent agency as well as external experts (which means they are also independent) not willing to endorse the drug is a bit dubious. Biogen obviously wants their drug approved despite “mixed data” because they’ve already spent millions on R&D and FDA trials…so for the sake of patients hopefully the risks would not be too much for the suggested benefits.

Sorry, this post has been deleted

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":114552759,"tweetId":"114552759","gmtCreate":1623081694471,"gmtModify":1704195767426,"author":{"id":3576275613425159,"idStr":"3576275613425159","authorId":3576275613425159,"authorIdStr":"3576275613425159","name":"Lynny","avatar":"https://static.tigerbbs.com/7c0b8b78e97626dedf9ed61da1957ab7","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":52,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Still looks rather controversial. With an&nbsp;independent agency as well as external experts&nbsp; (which means they are also independent) not willing to endorse the drug is a bit dubious. Biogen obviously wants their drug approved despite “mixed data” because they’ve already spent millions on R&amp;D and FDA trials…so&nbsp;for the sake of patients hopefully the risks would not be too&nbsp;much for the suggested benefits.&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>Still looks rather controversial. With an&nbsp;independent agency as well as external experts&nbsp; (which means they are also independent) not willing to endorse the drug is a bit dubious. Biogen obviously wants their drug approved despite “mixed data” because they’ve already spent millions on R&amp;D and FDA trials…so&nbsp;for the sake of patients hopefully the risks would not be too&nbsp;much for the suggested benefits.&nbsp;</p></body></html>","text":"Still looks rather controversial. With an independent agency as well as external experts (which means they are also independent) not willing to endorse the drug is a bit dubious. Biogen obviously wants their drug approved despite “mixed data” because they’ve already spent millions on R&D and FDA trials…so for the sake of patients hopefully the risks would not be too much for the suggested benefits.","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/114552759","repostId":1108033863,"repostType":4,"isVote":1,"tweetType":1,"viewCount":5228,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["BIIB"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":337,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/114552759"}